Fungemia

Fungemia
ICD-9	117.9
MeSH	D016469

WikiDoc Resources for Fungemia
Articles
Most recent articles on Fungemia Most cited articles on Fungemia Review articles on Fungemia Articles on Fungemia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fungemia Images of Fungemia Photos of Fungemia Podcasts & MP3s on Fungemia Videos on Fungemia
Evidence Based Medicine
Cochrane Collaboration on Fungemia Bandolier on Fungemia TRIP on Fungemia
Clinical Trials
Ongoing Trials on Fungemia at Clinical Trials.gov Trial results on Fungemia Clinical Trials on Fungemia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fungemia NICE Guidance on Fungemia NHS PRODIGY Guidance FDA on Fungemia CDC on Fungemia
Books
Books on Fungemia
News
Fungemia in the news Be alerted to news on Fungemia News trends on Fungemia
Commentary
Blogs on Fungemia
Definitions
Definitions of Fungemia
Patient Resources / Community
Patient resources on Fungemia Discussion groups on Fungemia Patient Handouts on Fungemia Directions to Hospitals Treating Fungemia Risk calculators and risk factors for Fungemia
Healthcare Provider Resources
Symptoms of Fungemia Causes & Risk Factors for Fungemia Diagnostic studies for Fungemia Treatment of Fungemia
Continuing Medical Education (CME)
CME Programs on Fungemia
International
Fungemia en Espanol Fungemia en Francais
Business
Fungemia in the Marketplace Patents on Fungemia
Experimental / Informatics
List of terms related to Fungemia

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Fungemia (also known as Candidemia, Candedemia, and Invasive Candidiasis) is the presence of fungi or yeasts in the blood. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, oncology patients, or in patients with intravenous catheters. Recently, it has been suggested the otherwise immunocompetent patients taking infliximab may be at a higher risk for fungemia.

The diagnosis is complicated, as routine blood cultures have poor sensitivity. Treatment involves use of antifungals, e.g. fluconazole or amphotericin.

The two most important risk factors are:

• Use of broad-spectrum antibiotics
• Colonization by fungi (see e.g. candidiasis)

Other risk factors are:

• Dialysis
• Diabetes
• Lowered intestinal flora
• Suppressed Immune system
• Central venous catheter
• High severity of illness
• Multiple abdominal surgeries
• Use of steroids
• burns

The most commonly known pathogen is Candida albicans, causing roughly 70% of fungemias, followed by Candida glabrata with 10%, and Aspergillus with 1%. However, the frequency of infection by T. glabrata, Candida tropicalis, C. krusei, and C. parapsilosis is increasing, especially when significant use of fluconazole is common.

Symptoms can range from mild to extreme, often described as extreme flu-like symptoms. Pain, mental disorders, chronic fatigue, infections, are a few of the long list of associated symptoms with Fungemia.

See also

• Bacteremia
• Candidiasis

External link

• Treatment of fungal infections